Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

FDA approves Tryngolza to reduce triglycerides, pancreatitis risk in hypertriglyceridemia

The FDA has approved olezarsen as the first and only therapy, alongside diet, to lower triglycerides and acute pancreatitis risk in patients with severe hypertriglyceridemia, according to a manufacturer press…